Browsing Category
Pharma Industry News
4747 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Top 5 PCSK9 inhibitor stocks to watch in 2025: From injectables to gene editing
Explore the top five PCSK9 inhibitor stocks—Amgen, Regeneron–Sanofi, Merck, Novartis, Verve—and what makes each a standout in cholesterol treatment in 2025.
Can ATX101 disrupt the multibillion-dollar post-surgical pain market?
Can Allay Therapeutics’ ATX101 replace opioids in post-surgical care? Read how this long-acting bupivacaine platform may disrupt the pain relief market by 2026.
Can vepdegestrant outperform elacestrant in the race for ESR1-mutant breast cancer dominance?
Vepdegestrant shows stronger PFS benefit than elacestrant in ESR1-mutant breast cancer. Can it become the new standard? Explore data, safety, and market outlook.
Unicycive (NASDAQ: UNCY) hit by FDA manufacturing concerns ahead of oxylanthanum carbonate decision
Unicycive’s NDA for oxylanthanum carbonate faces FDA manufacturing concerns. Key decision expected June 28. Read the stock outlook and next steps.
X4 Pharmaceuticals (NASDAQ: XFOR) gets FDA fast track for mavorixafor in chronic neutropenia
X4 Pharmaceuticals (XFOR) secures FDA Fast Track for mavorixafor in chronic neutropenia, targeting trial completion in 2025 and results in 2026.
Recursion Pharmaceuticals (NASDAQ: RXRX) stock rises after 20% workforce cut and pipeline reset
Recursion Pharmaceuticals (NASDAQ: RXRX) cuts 20% of workforce to extend runway and narrow pipeline focus—read what this means for its AI drug discovery strategy.
Can Merck rebuild its cardiovascular empire post-Keytruda? A closer look at its next decade of drug growth
With Keytruda’s patent expiry nearing, Merck is betting on enlicitide and sotatercept to build a new cardiovascular empire. Can it succeed?
Non-opioid pain drugs in 2025: Top clinical-stage biotechs to watch
Explore the top biotech companies leading the charge in non-opioid pain relief in 2025, from Allay Therapeutics to Vertex Pharmaceuticals.
FPT advances digital healthcare strategy in Vietnam with AI-led public-private model
FPT Corporation launches AI-driven PPP framework to transform Vietnam’s healthcare system, aligning with Vision 2045 goals and digital health policy targets.
Merck advances pimicotinib in China as Center for Drug Evaluation accepts TGCT marketing application following pivotal Phase 3 data
Merck’s TGCT treatment pimicotinib moves closer to approval in China after CDE accepts marketing application; global filings planned next.